Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Interest & Investment Income (2019 - 2025)

Pulmonx has reported Interest & Investment Income over the past 7 years, most recently at $611000.0 for Q3 2025.

  • Quarterly Interest & Investment Income fell 51.85% to $611000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Sep 2025, down 41.64% year-over-year, with the annual reading at $5.1 million for FY2024, 9.11% down from the prior year.
  • Interest & Investment Income was $611000.0 for Q3 2025 at Pulmonx, down from $723000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.5 million in Q4 2023 and troughed at $94000.0 in Q4 2021.
  • The 5-year median for Interest & Investment Income is $748000.0 (2022), against an average of $776631.6.
  • Year-over-year, Interest & Investment Income soared 1000.0% in 2021 and then crashed 51.85% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $94000.0 in 2021, then soared by 695.74% to $748000.0 in 2022, then soared by 106.02% to $1.5 million in 2023, then crashed by 32.19% to $1.0 million in 2024, then plummeted by 41.53% to $611000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Interest & Investment Income are $611000.0 (Q3 2025), $723000.0 (Q2 2025), and $864000.0 (Q1 2025).